Cannon Gillian — SEC Form 4 filings
SEC reporting owner CIK 1833910. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-21 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,190 shares, $63,237 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 1,190 shares @ $53.14 ($63,237) in Xenon Pharmaceuticals Inc., filed 2026-06-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Director | 4 | — | 1 leg · 1,190 sh · $63,237 | 7 |
| CORCEPT THERAPEUTICS INC (CORT) | Director | 4 | — | — | 6 |
Form 4 filings — Cannon Gillian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Sale (S): 1,190 @ $53.14 | EDGAR |
| 2026-06-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 2,645 · Option exercise (M): 2,645 (derivative) @ $0 · Grant/award (A): 10,507 (derivative) @ $0 · Grant/award (A): 1,593 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Gift (G): 7,393 @ $0 | EDGAR |
| 2025-09-08 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 11,000 @ $22.99 · Tax withholding (F): 3,607 @ $70.13 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 17,012 (derivative) @ $0 · Grant/award (A): 2,645 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 15,542 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1833910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →